Pharmacokinetic-Pharmacodynamic Model of Sufentanil for Target-controlled Infusion in Children

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000522

Enrollment

Registered

2012-09-04

Start date

2013-01-02

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : sufentanil continuous infusion blood sampling(12-18)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society Anesthesiologists class 1 or 2 2-12 years old general anesthesia get permission

Exclusion criteria

Exclusion criteria: cardiovascular disesea, respiratory disesea, kidney disesea, endocrine disesea, hematologic disesea, central nervous disesea, psychologic disease, encephalitis hx hypersensitivity

Design outcomes

Primary

Measure	Time frame
plasma concentration	—

Countries

Korea, Republic of

Contacts

Public ContactJi-Hyun Lee

Seoul National University Hospital

Outcome results